Gilead Sciences · 1 day ago
Senior Director, Enterprise & Employee Communications
Gilead Sciences is dedicated to creating a healthier world by tackling major diseases and developing innovative therapies. They are seeking an experienced communications leader to drive employee experience and change communications, shaping strategies related to corporate priorities and enhancing employee engagement across the organization.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Develop and execute strategic communications for high-profile initiatives across HR, Corporate Strategy, Operations, IT, and Real Estate
Serve as a trusted advisor to senior leaders and internal partners, ensuring decisions reflect the employee perspective
Design and implement employee-centered strategies for key moments (e.g., corporate strategy, culture, performance and compensation, talent development, and major change initiatives)
Elevate the Employee Communications & Engagement Center of Excellence by developing best practices and processes that strengthen the team’s operating model and enhance engagement with business partners
Support the creation of modern, effective communications approaches across internal channels, such as SharePoint, Viva Engage, etc
Develop communications materials, including plans, talking points, scripts, and Q&A documents; shape messaging to advance organizational priorities
Lead communications for change initiatives and organizational transformation, meeting fast-paced milestones while keeping employees at the center
Build strong relationships with internal stakeholders and manage relationships with external agency partners
Establish KPIs and feedback loops to measure effectiveness and inform strategy
Analyze and communicate results, using data to refine strategies and improve outcomes
Oversee internal communications channels and optimize for reach and impact
Qualification
Required
Bachelor's degree and 14+ years of relevant experience, or
Master's degree and 12+ years of experience
Ability to partner cross-functionally and manage high-stakes projects under tight deadlines
Executive presence and credibility to advise senior leaders and influence stakeholders across functions through collaboration and alignment, fostering trust in high-impact communications
Proven ability to develop and execute strategic internal communication plans
Strong strategic thinking and planning skills
Exceptional storytelling and writing abilities
Excellent interpersonal and relationship-building skills
Proficiency in change management strategies
Ability to define and measure employee engagement metrics
Strong project management capabilities
Ability to engage and manage multiple stakeholders
Curious with strong learning agility
Operationally excellent and resilient in a dynamic environment
Organized with a systematic approach to prioritization
Process-oriented to achieve business objectives
Ability to lead, attract, and retain diverse talent
Preferred
Track record of success in HR and people-related communications, strategy, and transformation within large, high-profile organizations
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Recent News
2025-12-30
BioWorld Financial Watch
2025-12-29
Company data provided by crunchbase